AIG
BCAB icon

American International Group’s BioAtla BCAB Stock Holding History

American International Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-436
Closed -$75K – 311
2024
Q1 		$75K Sell
436
-4
-0.9% -$497 ﹤0.01% 2665
2023
Q4 		$54.1K Sell
440
-2
-0.5% -$173 ﹤0.01% 2799
2023
Q3 		$37.5K Buy
442
+16
+4% +$2.04K ﹤0.01% 2892
2023
Q2 		$63.9K Buy
+426
New +$73.3K ﹤0.01% 2815
2022
Q2 		– Sell
-154
Closed -$39K – 3104
2022
Q1 		$39K Sell
154
-11
-7% -$4.6K ﹤0.01% 2920
2021
Q4 		$162K Sell
165
-5
-3% -$6.4K ﹤0.01% 2487
2021
Q3 		$250K Buy
170
+33
+24% +$64.3K ﹤0.01% 2290
2021
Q2 		$289 Buy
137
+2
+1% +$4.52K ﹤0.01% 2274
2021
Q1 		$343 Buy
+135
New +$346K ﹤0.01% 2048

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

American International Group's BCAB Position: Q2 2024 in Review

American International Group sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 436 shares — an estimated $75K sold.

American International Group first reported a position in BCAB in Q1 2021 and held it in 9 quarters. The position peaked at $250K in Q3 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • American International Group reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 436 BioAtla shares in Q2 2024, an estimated $75K.
  • American International Group first reported a position in BioAtla in Q1 2021 and held it in 9 quarters.
  • American International Group's BioAtla position peaked at $250K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.